Haleon plc (NYSE:HLN) Stock Position Boosted by Pinnacle Bancorp Inc.

Pinnacle Bancorp Inc. grew its stake in shares of Haleon plc (NYSE:HLN) by 29.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,188 shares of the company’s stock after buying an additional 1,421 shares during the quarter. Pinnacle Bancorp Inc.’s holdings in Haleon were worth $53,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in HLN. Wellington Management Group LLP raised its holdings in Haleon by 164.6% during the fourth quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after purchasing an additional 8,423,475 shares in the last quarter. Cambiar Investors LLC acquired a new stake in shares of Haleon in the fourth quarter valued at $15,225,000. Goldman Sachs Group Inc. boosted its stake in Haleon by 19.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,813,997 shares of the company’s stock valued at $39,619,000 after buying an additional 772,829 shares in the last quarter. Optiver Holding B.V. grew its holdings in Haleon by 223.0% during the fourth quarter. Optiver Holding B.V. now owns 1,008,565 shares of the company’s stock worth $8,260,000 after acquiring an additional 696,327 shares during the period. Finally, Clearbridge Investments LLC grew its holdings in Haleon by 2.4% during the fourth quarter. Clearbridge Investments LLC now owns 26,581,902 shares of the company’s stock worth $218,769,000 after acquiring an additional 612,400 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Stock Down 1.9 %

Shares of NYSE:HLN opened at $8.27 on Friday. The company has a market cap of $37.76 billion, a PE ratio of 27.57, a price-to-earnings-growth ratio of 2.24 and a beta of 0.26. Haleon plc has a 52 week low of $7.70 and a 52 week high of $8.96. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.73 and a current ratio of 1.04. The firm has a 50 day simple moving average of $8.41 and a 200 day simple moving average of $8.34.

Haleon (NYSE:HLN) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.01. Haleon had a net margin of 9.68% and a return on equity of 13.17%. The firm had revenue of $3.70 billion for the quarter, compared to analyst estimates of $3.71 billion. As a group, research analysts expect that Haleon plc will post 0.46 earnings per share for the current year.

Wall Street Analyst Weigh In

HLN has been the subject of several research reports. HSBC began coverage on shares of Haleon in a research report on Wednesday, April 17th. They set a “buy” rating for the company. Argus restated a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. Finally, Berenberg Bank began coverage on Haleon in a research report on Wednesday, June 5th. They set a “buy” rating for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.